These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. Evaluation of complete cytoreductive surgery and two intraperitoneal chemotherapy techniques in Pseudomyxoma peritonei. Sørensen O; Flatmark K; Reed W; Wiig JN; Dueland S; Giercksky KE; Larsen SG Eur J Surg Oncol; 2012 Oct; 38(10):969-76. PubMed ID: 22763244 [TBL] [Abstract][Full Text] [Related]
3. Effective therapy for peritoneal dissemination in gastric cancer. Yonemura Y; Bandou E; Kinoshita K; Kawamura T; Takahashi S; Endou Y; Sasaki T Surg Oncol Clin N Am; 2003 Jul; 12(3):635-48. PubMed ID: 14567022 [TBL] [Abstract][Full Text] [Related]
4. Are there curative options to peritoneal carcinomatosis? Sugarbaker PH Ann Surg; 2005 Nov; 242(5):748-50; author reply 750-1. PubMed ID: 16244553 [No Abstract] [Full Text] [Related]
5. Cytoreductive surgery with selective versus complete parietal peritonectomy followed by hyperthermic intraperitoneal chemotherapy in patients with diffuse malignant peritoneal mesothelioma: a controlled study. Baratti D; Kusamura S; Cabras AD; Deraco M Ann Surg Oncol; 2012 May; 19(5):1416-24. PubMed ID: 22302266 [TBL] [Abstract][Full Text] [Related]
6. Cytoreductive surgery and peri-operative intraperitoneal chemotherapy as a curative approach to pseudomyxoma peritonei syndrome. Sugarbaker PH Eur J Surg Oncol; 2001 Apr; 27(3):239-43. PubMed ID: 11373099 [TBL] [Abstract][Full Text] [Related]
8. Critical assessment of preoperative and operative risk factors for complications after iterative peritonectomy procedures. Saxena A; Yan TD; Morris DL Eur J Surg Oncol; 2010 Mar; 36(3):309-14. PubMed ID: 19615849 [TBL] [Abstract][Full Text] [Related]
9. Two-stage operative cytoreduction and intraperitoneal chemotherapy for diffuse malignant peritoneal mesothelioma: Operative morbidity and mortality in phase I and II trials. Kluger MD; Taub RN; Hesdorffer M; Jin Z; Chabot JA Eur J Surg Oncol; 2010 Oct; 36(10):997-1003. PubMed ID: 20674253 [TBL] [Abstract][Full Text] [Related]
10. An update of peritonectomy procedures used in cytoreductive surgery for peritoneal malignancy. Mercier F; Mohamed F; Cazauran JB; Kepenekian V; Vaudoyer D; Cotte E; Glehen O; Passot G Int J Hyperthermia; 2019; 36(1):744-752. PubMed ID: 31401893 [No Abstract] [Full Text] [Related]
12. Total extraperitoneal access for parietal peritonectomy for peritoneal surface malignancy: The 'cocoon' technique. Kyriazanos I; Papageorgiou D; Zoulamoglou M; Marougkas M; Stamos N; Ivros N; Kalles V Eur J Obstet Gynecol Reprod Biol; 2020 Aug; 251():258-262. PubMed ID: 32563137 [TBL] [Abstract][Full Text] [Related]
13. Clinico-pathological outcomes after total parietal peritonectomy, cytoreductive surgery and hyperthermic intraperitoneal chemotherapy in advanced serous papillary peritoneal carcinoma submitted to neoadjuvant systemic chemotherapy- largest single institute experience. Deraco M; Sinukumar S; Salcedo-Hernández RA; Rajendra VJ; Baratti D; Guaglio M; Nizri E; Kusamura S Eur J Surg Oncol; 2019 Nov; 45(11):2103-2108. PubMed ID: 31230982 [TBL] [Abstract][Full Text] [Related]
14. Long-term survival of a patient with primary papillary serous carcinoma of the peritoneum treated by subtotal peritonectomy plus intraoperative chemohyperthermia. Ajisaka H; Yonemura Y; Bando E; Fushida S; Nishimura G; Miwa K Hepatogastroenterology; 2002; 49(46):1027-9. PubMed ID: 12143193 [TBL] [Abstract][Full Text] [Related]
15. [Treatment results of peritoneal dissemination from gastric cancer by neoadjuvant intraperitoneal-systemic chemotherapy]. Yonemura Y; Kawamura T; Bando E; Takahashi S; Sawa T; Yoshimitsu Y; Obata T; Endo Y; Sasaki T; Sugarbaker PH Gan To Kagaku Ryoho; 2004 Oct; 31(11):1723-6. PubMed ID: 15553695 [TBL] [Abstract][Full Text] [Related]
16. Diaphragmatic peritonectomy vs. full thickness resection with pleurectomy during Visceral-Peritoneal Debulking (VPD) in 100 consecutive patients with stage IIIC-IV ovarian cancer: A surgical-histological analysis. Soleymani Majd H; Ferrari F; Manek S; Gubbala K; Campanile RG; Hardern K; Tozzi R Gynecol Oncol; 2016 Mar; 140(3):430-5. PubMed ID: 26691220 [TBL] [Abstract][Full Text] [Related]
17. Total parietal peritonectomy with en bloc pelvic resection for advanced ovarian cancer with peritoneal carcinomatosis. Kim HS; Bristow RE; Chang SJ Gynecol Oncol; 2016 Dec; 143(3):688-689. PubMed ID: 27743737 [TBL] [Abstract][Full Text] [Related]
18. Peritonectomy for peritoneal carcinomatosis: long-term outcomes from a single Brazilian institution. Akaishi E; Teixeira F; Katayama M; Mizumoto N; Costa FP; Buzaid AC; Hoff PM World J Surg; 2009 Apr; 33(4):835-9; discussion 840. PubMed ID: 19169741 [TBL] [Abstract][Full Text] [Related]
19. [Peritonectomy and intraperitoneal chemotherapy--new methods in multi-modality therapy of peritoneal carcinosis]. Jähne J; Piso P Langenbecks Arch Chir Suppl Kongressbd; 1998; 115():1435-7. PubMed ID: 9931904 [TBL] [Abstract][Full Text] [Related]
20. Primary peritonectomy/HIPEC for disseminated peritoneal adenomucinosis achieves much lower recurrence rates and better survival than secondary procedures. Zhu KJ; Morris DL Surgeon; 2009 Dec; 7(6):345-50. PubMed ID: 20681377 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]